Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
7 Dec 2020	Submitted	Original manuscript
9 Dec 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
9 Dec 2020	Editorially accepted
6 Jan 2021	Article published	10.1186/s13063-020-04964-1

Back to article page